We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stent Grafts Superior to Balloon Angioplasty in Dialysis Patients

By HospiMedica International staff writers
Posted on 25 Feb 2010
Expanded polytetrafluoroethylene (PTFE) endovascular stent grafts are better than conventional balloon angioplasty in revision of failing arteriovenous (AV) hemodialysis grafts, according to a new study. More...


Researchers at the University of Maryland Medical Center (UMM, Baltimore, USA) conducted a prospective, random multicenter trial that assigned 190 patients (69 men, 121 women) with failing AV grafts in 13 institutions to undergo either balloon angioplasty alone, or balloon angioplasty plus placement of a PTFE endovascular stent graft. A total of 97 patients received stent grafts, and 93 underwent percutaneous transluminal angioplasty (PTA). Primary end points included patency of the treatment area and patency of the entire vascular access circuit.

The results showed that nearly 51% of dialysis accesses treated with stent grafts remained open (patent) at six months, as compared to just 23% of those treated with balloon angioplasties. The same was true of the incidence of patency of the access circuit (38% compared to 20%), as was the incidence of freedom from subsequent interventions at 6 months (32% in the stent-graft group compared to 16% in the balloon-angioplasty group). The incidences of adverse events at six months were equivalent in the two treatment groups, with the exception of restenosis, which occurred more frequently in the balloon-angioplasty group. Additionally, the treating physicians had a nearly 94% success rate at implanting the stent grafts. The study was published in the February 11, 2010, issue of the New England Journal of Medicine (NEJM).

"Stent grafts overwhelmingly performed better than balloon angioplasty for maintaining access in dialysis patients, providing superior patency and freedom from repeat interventions,” said study coauthor Ziv Haskal, M.D., of UMM. "Stent grafts provide clear improvement over balloon angioplasty by prolonging the function of a patient's bypass without surgery - helping individuals avoid additional invasive procedures and time in the hospital.”

When kidneys fail - called chronic kidney or end-stage renal disease - treatment in the form of regular dialysis (or hemodialysis) is needed to take over the failing kidney's function to maintain fluid, electrolyte and acid-base balance. Before dialysis can begin, patients often have a vascular access graft surgically placed in the arm to provide a high-flow site, allowing high flow of blood from the artery into the vein. The leading cause of failure of a prosthetic AV hemodialysis-access graft is venous anastomotic stenosis. The failing grafts cause considerable morbidity, discomfort, and inconvenience for dialysis patients, due to the need for invasive procedures to reestablish access flow or graft abandonment and reoperation.

Related Links:

University of Maryland Medical Center




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.